CellOxess Competitors and Similar CompaniesClear all
CellOxess's competitors and similar companies include Inflazome, SiteOne Therapeutics, Labcorp and Quanterix.
 Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. |  SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. |  Labcorp Labcorp (also known as Laboratory Corporation of America Holdings) is a life sciences company that provides diagnostic, drug development, and technology-enabled solutions. |  Quanterix Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches. | ||
Founding Date | Founding Date 1990 | Founding Date 2016 | Founding Date 2014 | Founding Date 1995 | Founding Date 2007 |
Type | Type Private | Type Subsidiary | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Ewing Township, US HQ | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations San Francisco, US HQ Bozeman, US | Locations Billerica, US HQ Baltimore, US Philadelphia, US San Diego, US San Francisco, US Seattle, US | |
Employees | Employees 4 | Employees 156% decrease | Employees 2216% increase | Employees 70,0004% increase | Employees 24840% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 75 m | Valuation ($) N/A | Valuation ($) 506.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $13b (FY, 2024) | Revenue (est.) $138.9m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $9.4b (FY, 2024) | Cost of goods $73.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $3.6b (FY, 2024) | Gross profit $65m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income $747.1m (FY, 2024) | Net income ($107.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 17m | Total funding raised $ 17.8m | Total funding raised $ 350m | Total funding raised $ 96.5m |
For sources of this data, please see the company profile
View Company Profiles
Inflazome
HQ
Dublin 2, IE
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View companySiteOne Therapeutics
HQ
San Francisco, US
Employees
22↑ 16% increase
SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
View companyLabcorp
HQ
Burlington, US
Labcorp (also known as Laboratory Corporation of America Holdings) is a life sciences company that provides diagnostic, drug development, and technology-enabled solutions.
View companyQuanterix
HQ
Billerica, US
Employees
248↑ 40% increase
Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches.
View company